Block.one, the company behind EOSIO (EOS), granted the Genobank a $ 50,000 grant on April 29 for their open source application. The grant is intended to facilitate anonymous access to COVID-19 tests.
Genobank announced in early April that its Agerona app will be developed in collaboration with the Eos-based blockchain platform Telos.
Block.one granted the grant in cooperation with its venture capital wing EOS VC and the German fintech incubator FinLab EOS VC..
Block.one invests in the Eos-based test application COVID-19
Agerona connects users anonymously to test providers in their country. The tests contain unique barcodes that are used to create a free, anonymous account in the Telos blockchain for the user. The kits are sent to a verified laboratory for processing – Uploaded anonymously to the blockchain with the results.
The system enables test results to be analyzed by health researchers without being linked to the identity of the people being analyzed.
The CEO of Genobank, Daniel Uribe said, “We are grateful to support and support Block.one’s business, EOS VC, to support our efforts to anonymize test kits. DNA / RNA (including coronavirus), while allowing patients and users to decide whether to make their anonymized data available to the scientific community to control the spread of the coronavirus and potentially contribute to treatment. “
The managing director of Block.one, Brendan Blumer, said: “We have seen the growth of an open source community, whose passion and innovation have helped identify and solve critical business problems ranging from arts to wellness.”.
Block.one invests in several companies fighting corona virus
Block.one has funded several companies that are working on solutions to problems related to COVID-19. The company achieved this by working with the EOS VC funding program and working with FinLab EOS VC.
The recipients include the health and wellness platform PUML Better Health, the employment platform Moonlighting and the AI service Innoplexus.
“With the emergence of pressing global problems caused by the corona virus, it is important that we strengthen and support the way blockchain technology is used to provide solutions,” said Blumer.
Recommended blockchain use cases in the midst of a corona virus pandemic
Many of the benefits of distributed ledger technology (DLT) have been highlighted in recent initiatives in response to COVID-19.
April 29th The UK Open University has started testing a blockchain-based immunity test app for COVID-19. The prototype tries to protect privacy Offers tamper-proof test results to check immunity.
April 26th Cointelegraph reported that New York’s largest hospital network had joined IBM’s Rapid Supplier Connect network, a blockchain-based network for the verification of providers of COVID-19 auxiliary products and for connecting providers with buyers.
In April ConsenSys developers working on the baseline protocol have proposed a system for tracking coronavirus contacts. The aim is to address the potential risks of data protection, falsification of records and the centralization of data mentioned in the Apple and Google proposals.